KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardlytics (CDLX) Common Equity (2016 - 2026)

Cardlytics filings provide 11 years of Common Equity readings, the most recent being -$4.0 million for Q1 2026.

  • Quarterly Common Equity fell 106.25% to -$4.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$4.0 million through Mar 2026, down 106.25% year-over-year, with the annual reading at -$6.5 million for FY2025, 109.3% down from the prior year.
  • Common Equity hit -$4.0 million in Q1 2026 for Cardlytics, up from -$6.5 million in the prior quarter.
  • Across five years, Common Equity topped out at $711.7 million in Q1 2022 and bottomed at -$6.5 million in Q4 2025.
  • Average Common Equity over 5 years is $209.0 million, with a median of $199.1 million recorded in 2024.
  • The largest annual shift saw Common Equity fell 4.46% in 2022 before it plummeted 109.3% in 2025.
  • Cardlytics' Common Equity stood at $211.6 million in 2022, then crashed by 36.3% to $134.8 million in 2023, then plummeted by 48.08% to $70.0 million in 2024, then plummeted by 109.3% to -$6.5 million in 2025, then surged by 38.49% to -$4.0 million in 2026.
  • Per Business Quant, the three most recent readings for CDLX's Common Equity are -$4.0 million (Q1 2026), -$6.5 million (Q4 2025), and -$4.7 million (Q3 2025).